Melinda Lackey's most recent trade in Alaunos Therapeutics Inc was a trade of 1,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Melinda Lackey | Legal & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2025 | 1,000 | 1,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Melinda Lackey | Legal & Administration | 14 Aug 2024 | 1,500 | 1,500 | - | - | Employee Stock Option (right to buy) | ||
| Alaunos Therapeutics Inc | Melinda Lackey | See Remarks | 15 Mar 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | ||
| Alaunos Therapeutics Inc | Melinda Lackey | Senior Vice President, Legal | 15 Sep 2022 | 185,000 | 185,000 | - | - | Employee Stock Option (right to buy) | ||
| Alaunos Therapeutics Inc | Melinda Lackey | Senior Vice President, Legal | 10 Dec 2021 | 370,000 | 370,000 | - | - | Employee Stock Option (Right to Buy) |